AI Tokens
Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Adjustments to Financial Statements

Microsoft Excel

Adjustments to Current Assets

Shockwave Medical Inc., adjusted current assets

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Current assets 1,225,260 459,263 285,902 246,300 216,697
Adjustments
Add: Allowance for doubtful accounts 2,179 710 350 380 194
After Adjustment
Adjusted current assets 1,227,439 459,973 286,252 246,680 216,891

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


A significant and accelerating upward trend in current assets is observed from 2019 through 2023. The growth trajectory shifted from steady incremental increases between 2019 and 2021 to exponential growth in 2022 and 2023, with current assets increasing from 216,697 thousand US dollars in 2019 to 1,225,260 thousand US dollars by the end of 2023.

Growth Velocity
The rate of expansion in current assets intensified markedly in the latter part of the period. While growth was moderate between 2019 and 2021, a substantial surge occurred in 2022, followed by a peak increase in 2023, where assets grew by approximately 166.8% over the preceding year.
Analysis of Asset Adjustments
Adjusted current assets consistently track slightly above the reported current assets across all five years. The absolute variance between the two figures grew from 194 thousand US dollars in 2019 to 2,179 thousand US dollars in 2023, mirroring the general growth in the overall asset base.
Materiality of Adjustments
The adjustments made to current assets are considered immaterial in relation to the total volume of assets. The variance consistently represents a negligible percentage of the total, remaining well below 0.2% throughout the analyzed period, indicating that the adjustments do not significantly alter the company's liquidity profile or financial position.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjustments to Total Assets

Shockwave Medical Inc., adjusted total assets

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Total assets 1,566,563 646,089 345,682 272,042 231,938
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1 — — — — —
Add: Allowance for doubtful accounts 2,179 710 350 380 194
Less: Deferred tax assets2 99,169 97,568 — — —
After Adjustment
Adjusted total assets 1,469,573 549,231 346,032 272,422 232,132

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred tax assets. See details »


Between December 31, 2019, and December 31, 2023, there is a significant and accelerating upward trend in both total assets and adjusted total assets. The growth remains moderate through 2021, followed by a substantial increase in 2022 and a further surge in 2023, indicating a period of rapid balance sheet expansion.

Asset Growth Patterns
Total assets grew from 231,938 thousand US$ in 2019 to 1,566,563 thousand US$ by 2023. This represents a total increase of approximately 575% over the five-year period. The most aggressive growth occurred between 2022 and 2023, where assets more than doubled in a single fiscal year.
Analysis of Asset Adjustments
From 2019 to 2021, the variance between total assets and adjusted total assets was negligible, with differences remaining under 400 thousand US$. However, a significant divergence emerged starting in 2022. In 2022, total assets exceeded adjusted total assets by 96,858 thousand US$, and in 2023, this gap remained consistent at 96,990 thousand US$.
Interpretation of Divergence
The stability of the adjustment amount across 2022 and 2023—remaining near 97 million US$—suggests the exclusion of a specific, non-operating or one-time asset component from the adjusted total. While the overall asset base continued to grow exponentially, the adjustment factor remained static, causing the adjusted total assets to track the general growth trend while maintaining a constant offset from the nominal total.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjustments to Total Liabilities

Shockwave Medical Inc., adjusted total liabilities

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Total liabilities 897,886 134,773 103,852 46,388 39,285
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1 — — — — —
Less: Deferred tax liabilities2 3,609 — — — —
After Adjustment
Adjusted total liabilities 894,277 134,773 103,852 46,388 39,285

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred tax liabilities. See details »


A significant escalation in total obligations is evident over the five-year period ending December 31, 2023. From 2019 through 2022, liabilities grew at a moderate pace, followed by an exponential increase in the final reporting year, where total liabilities rose from 134,773 thousand USD to 897,886 thousand USD.

Liability Growth Trend
Between 2019 and 2022, total liabilities increased from 39,285 thousand USD to 134,773 thousand USD, representing a steady upward trajectory. However, the transition into 2023 shows a sharp surge, with liabilities increasing by approximately 566% within a single fiscal year.
Adjustment Analysis
For the period spanning 2019 to 2022, no divergence is observed between total liabilities and adjusted total liabilities, indicating that no adjustments were deemed necessary during these years. In 2023, a variance emerges, with adjusted total liabilities reported at 894,277 thousand USD against a total liability figure of 897,886 thousand USD.
Magnitude of 2023 Adjustment
The adjustment in the 2023 fiscal year represents a reduction of 3,609 thousand USD from the total liabilities. Despite the massive increase in the overall scale of obligations, this specific adjustment remains relatively minor, constituting approximately 0.4% of the total liability balance for that year.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjustments to Stockholders’ Equity

Shockwave Medical Inc., adjusted stockholders’ equity

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Stockholders’ equity 668,677 511,316 241,830 225,654 192,653
Adjustments
Less: Net deferred tax assets (liabilities)1 95,560 97,568 — — —
Add: Allowance for doubtful accounts 2,179 710 350 380 194
After Adjustment
Adjusted stockholders’ equity 575,296 414,458 242,180 226,034 192,847

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Net deferred tax assets (liabilities). See details »


A consistent upward trajectory is observed in both stockholders' equity and adjusted stockholders' equity between 2019 and 2023. Growth remained moderate from 2019 through 2021, followed by a substantial acceleration in 2022 and continued expansion in 2023.

Equity Growth Trends
Stockholders' equity increased from 192,653 thousand US dollars in 2019 to 668,677 thousand US dollars by 2023. The most pronounced increase occurred between 2021 and 2022, where the balance grew by approximately 111%. Adjusted stockholders' equity followed a similar growth path, rising from 192,847 thousand US dollars in 2019 to 575,296 thousand US dollars in 2023.
Adjustment Variance Analysis
For the period spanning 2019 to 2021, the variance between reported stockholders' equity and adjusted stockholders' equity was negligible, indicating that minimal adjustments were necessary during those years. A significant divergence emerged in 2022, where reported stockholders' equity exceeded adjusted stockholders' equity by 96,858 thousand US dollars. This gap persisted into 2023, with reported equity remaining 93,381 thousand US dollars higher than the adjusted figure.
Comparative Expansion Rates
The acceleration of equity in 2022 was more aggressive in the reported figures than in the adjusted figures. While reported stockholders' equity grew by over 111% between 2021 and 2022, adjusted stockholders' equity grew by approximately 71% during the same interval. This suggests that a substantial portion of the equity increase in the latter years is attributable to items removed during the adjustment process.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjustments to Capitalization Table

Shockwave Medical Inc., adjusted capitalization table

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Debt, current portion — — 5,500 3,300 6,667
Convertible debt, noncurrent portion 731,863 — — — —
Debt, noncurrent portion — 24,198 11,630 13,319 7,152
Total reported debt 731,863 24,198 17,130 16,619 13,819
Stockholders’ equity 668,677 511,316 241,830 225,654 192,653
Total reported capital 1,400,540 535,514 258,960 242,273 206,472
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1 — — — — —
Add: Operating lease liability, current portion2 3,641 1,278 1,738 873 774
Add: Operating lease liability, noncurrent portion3 35,103 34,928 28,321 7,488 8,125
Adjusted total debt 770,607 60,404 47,189 24,980 22,718
Adjustments to Equity
Less: Net deferred tax assets (liabilities)4 95,560 97,568 — — —
Add: Allowance for doubtful accounts 2,179 710 350 380 194
Adjusted stockholders’ equity 575,296 414,458 242,180 226,034 192,847
After Adjustment
Adjusted total capital 1,345,903 474,862 289,369 251,014 215,565

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Operating lease liability, current portion. See details »

3 Operating lease liability, noncurrent portion. See details »

4 Net deferred tax assets (liabilities). See details »


The financial structure of the organization experienced substantial expansion between 2019 and 2023, transitioning from a low-leverage position to a highly leveraged capital base. The most significant volatility occurred in the final year of the period, driven by a surge in debt obligations.

Debt Obligations and Adjustments
Total reported debt remained relatively stable from 2019 to 2022, moving from US$ 13.8 million to US$ 24.2 million. However, a sharp increase is observed in 2023, with reported debt escalating to US$ 731.9 million. Adjusted total debt consistently exceeds reported debt across all five years, suggesting the consistent inclusion of additional liabilities. This adjustment gap was most pronounced relative to the total in 2022 and remained significant in 2023, where adjusted debt reached US$ 770.6 million.
Equity Trends and Capital Adjustments
Stockholders' equity demonstrated a steady upward trajectory, growing from US$ 192.7 million in 2019 to US$ 668.7 million in 2023. A critical shift in adjustment patterns occurred in 2022; prior to this, adjusted equity was marginally higher than reported equity, but from 2022 onward, adjusted equity became significantly lower than reported figures, ending at US$ 575.3 million in 2023.
Aggregate Capitalization Analysis
Total reported capital increased from US$ 206.5 million in 2019 to US$ 1.4 billion in 2023. While adjusted total capital followed a similar growth path, it diverged from reported capital in the later years. By 2023, adjusted total capital stood at US$ 1.35 billion, which is lower than the reported total. The overall capital composition shifted dramatically in 2023, as the surge in debt obligations became the primary driver of the total capitalization increase.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjustments to Reported Income

Shockwave Medical Inc., adjusted net income (loss)

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Net income (loss) 147,278 215,996 (9,136) (65,699) (51,109)
Adjustments
Add: Deferred income tax expense (benefit)1 14,708 (97,276) — — —
Add: Increase (decrease) in allowance for doubtful accounts 1,469 360 (30) 186 118
Add: Other comprehensive income (loss) 1,160 (665) (211) (26) 35
After Adjustment
Adjusted net income (loss) 164,615 118,415 (9,377) (65,539) (50,956)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Deferred income tax expense (benefit). See details »


A transition from sustained operational losses to profitability is observed over the five-year period from 2019 to 2023. While the company experienced deepening losses in 2020, a significant recovery trend began in 2021, leading to a pivot to positive net income by 2022.

Profitability Trajectory
Net losses were recorded from 2019 through 2021, peaking at a loss of 65.7 million US dollars in 2020. A substantial reduction in losses occurred in 2021, followed by a shift to a positive net income of 216 million US dollars in 2022. Although reported net income decreased to 147.3 million US dollars in 2023, the company maintained a profitable state.
Analysis of Adjusted Net Income
Adjusted net income closely tracked reported net income during the loss-making years of 2019 to 2021. However, a divergence emerged in the profitability phase. In 2022, reported net income significantly exceeded adjusted net income, suggesting the presence of substantial non-recurring gains or one-time credits. By 2023, this trend reversed, with adjusted net income rising to 164.6 million US dollars, surpassing reported net income by approximately 17.3 million US dollars.
Variance and Adjustment Patterns
The relationship between reported and adjusted figures indicates a shift in the nature of non-operational items. Between 2019 and 2021, adjustments were negligible. The 2022 fiscal year shows a high positive variance in reported income, while 2023 reflects a pattern where adjusted income is used to neutralize expenses that reduced the reported bottom line, highlighting a trend of improving adjusted operational performance despite fluctuations in reported net income.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?